Lansinoh Pain Relieving Spray
Product Images NDC 53997-001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lansinoh Pain Relieving (NDC 53997-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lansinoh Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lidocaine Carton (Lidocaine Carton Final V2 Dl)

Lidocaine Carton (Lidocaine Carton Final V2 Dl)
This is a Drug Facts sheet for a postpartum pain relief spray containing lidocaine (4%) and herbal ingredients such as witch hazel and aloe vera. The spray aims to temporarily relieve pain and is intended for external use only. The product has been dermatologically and gynecologically tested and comes with a warning to not use on infants or children under the age of 12, or on breasts, nipples, or around the mouth. The user should avoid contact with eyes, large quantities, or raw surfaces. The product can be applied externally to the affected area up to 3-4 times in a 24-hour period, but if symptoms persist or worsen, one should contact a doctor for medical assistance. The product is distributed by Lansinoh Laboratories, Inc. and comes with a 360° sprayer for easy, hands-free application.*
FDA Label Image

Lidocaine Label (Lidocaine Label Final V2 Dl)

Lidocaine Label (Lidocaine Label Final V2 Dl)
This is a drug facts label for Lansinoh Pain Relief Spray with 4% Lidocaine. The product is intended for adult use only and is applied externally to temporarily relieve pain. The label includes directions for use, warnings, and a list of inactive ingredients. The spray is manufactured by Lansinoh Laboratories in Alexandria, VA. The label warns to avoid contact with eyes and not to use the product over raw surfaces or blistered areas. The label also warns not to use the product on infants or children under 12 and to consult a doctor if the condition worsens or symptoms persist for more than 7 days.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.